Funder
National Institute of Neurological Disorders and Stroke
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison
Publisher
Springer Science and Business Media LLC
Reference81 articles.
1. Bloch-Gallego, E. (2015). Mechanisms controlling neuromuscular junction stability. Cellular and Molecular Life Sciences, 72(6), 1029–1043. https://doi.org/10.1007/s00018-014-1768-z.
2. Lodish, H., Berk, A., Zipursky, S. L., Matsudaira, P., Baltimore, D., & Darnell, J. (2000). Section 21.5 Neurotransmitter receptors. In Molecular Cell Biology. 4th Edn. W.H. Freeman.
3. Morrison, B. M. (2016). Neuromuscular diseases. Seminars in Neurology, 36(5), 409–418. https://doi.org/10.1055/s-0036-1586263.
4. Souto, E. B., Lima, B., Campos, J. R., Martins-Gomes, C., Souto, S. B., & Silva, A. M. (2019). Myasthenia gravis: State of the art and new therapeutic strategies. Journal of Neuroimmunology, 337, 577080. https://doi.org/10.1016/j.jneuroim.2019.577080.
5. Krakora, D., Macrander, C., & Suzuki, M. (2012). Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis. Neurology Research International, 2012, 379657. https://doi.org/10.1155/2012/379657.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献